Creatine kinase levels in patients with bipolar disorder: Depressive, manic, and euthymic phases;Comparação das fases de depressão, mania e eutimia sobre os níveis de creatina quinase em pacientes bipolares

Revista Brasileira de Psiquiatria

Volumn 33, Issue 2, 2011, Pages 171-175

  Feier, Gustavo ^a   Valvassori, Samira S ^a   Rezin, Gislaine T ^b   Búrigo, Márcio ^b   Streck, Emilio L ^b   Kapczinski, Flávio ^c   Quevedo, João ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b Universidade do Extremo Sul de Santa Catarina (UNESC)   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Bipolar disorder; Case control studies; Creatine kinase; Depression; Water level measurement adverse effects

Indexed keywords

CREATINE KINASE;

ADULT; ARTICLE; BIPOLAR DISORDER; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HAMILTON SCALE; HUMAN; MALE; MANIA; MENTAL DISEASE; NERVE CELL; YOUNG MANIA RATING SCALE;

EID: 80051478895     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462011005000005     Document Type: Article

References (26)

1. APA - American Psychiatric Association. DSM-IV: diagnostic and statistical manual of mental disorders. 4th ed. New York: American Psychiatric Association; 1994.
2. Coryell W, Scheftner W, Keller M, Endicott J, Maser J, Lklerman G. The enduring psychological consequences of mania and depression. Am J Psychiatry. 1993;150(5):720-727.
3. Yuan-Who C, Dilsaver SC. Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other axis I disorders. Biol Psychiatry. 1996;39(10):896-899.
4. Andres RH, Ducray AD, Schlattner U, Wallimann T, Widmer HR. Functions and effects of creatine in the central nervous system. Brain Res Bull. 2008;76(4):329-343.
5. Meltzer HY. Neuromuscular dysfunction in schizophrenia. Schizophr Bull. 1976;2(1):106-135.
6. Meltzer HY, Ross-Stanton J, Schlessinger S. Mean serum creatine kinase activity in patients with functional psychoses. Arch Gen Psychiatry. 1980;37(6):650-655.
7. Hatta k, Takahashi T, Nakamura H, Yamashiro H, Endo H, Fujii S, Fukami G, Masui K, Asukai N, Yonezawa Y. Abnormal physiological conditions in acuteschizophrenic patients on emergency admission: dehydration, hypokalemia, leukocytosis and elevated muscle enzymes. Eur Arch Psychiatry Clin Neurosci. 1998;248(4):180-188.
8. Hermesh H, Manor I, Shiloh R, Weizman R, Munitz H. Absence of myoglobinuria in acute psychosis with marked elevation in serum creatine phosphokinase level. Eur Neuropsychopharmacol. 2001;11(2):111-115.
9. Hermesh H, Manor I, Shiloh R, Aizenberg D, Benjamini Y, Munitz H, Weizmann A. High serum creatine kinase level: possible risk factor for neuroleptic malignant syndrome. J Clin Psychopharmacol. 2002;22(3):252-256.
10. MacDonald ML, Naydenov A, Chu M, Matzilevich D, Konradi C. Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. Bipolar Disord. 2006;8(3):255A-264A.
11. Segal M, Avital A, Drobot M, Lukanin A, Derevenski A, Sandbank S, Weizman A. CK levels in unmedicated bipolar patients. Eur Neuropsychopharmacol. 2007;17(12):763-767.
12. Vale S, Espejel MA, Calcaneo F, Ocampo J, Diaz-de-Leon J. Creatine phosphokinase. Increased activity of the spina fuid in psychotic patients. Arch Neurol. 1974;30(1):103-104.
13. Rosalki SB. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med. 1967;69(4):696-705.
14. Manor I, Hermesh H, Valevski A, Benjamin Y, Munitz H, Weizman A. Recurrence pattern of serum creatine phosphokinase levels in repeated acute psychosis. Biol Psychiatry. 1998;43(4):288-92.
15. Taylor JR, Abichandani L. Creatine phosphokinase elevations and psychiatric symptomatology. Biol Psychiatry. 1980;15(6):865-870.
16. Hough CJ, Chuang DM. The mitochondrial hypothesis of bipolar disorder. Bipolar Disord. 2000;2(3 Pt 1):145-147.
17. Kato T, Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord. 2000;2(3 Pt 1):180-190.
18. Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry. 2004;61(3):300-308.
19. Rezin GT, Amboni G, Zugno AI, Quevedo J, Streck EL. Mitochondrial dysfunction and psychiatric disorders. Neurochem Res. 2009;34(6):1021-1029.
20. Streck EL, Amboni G, Scaini G, Di-Pietro PB, Rezin GT, Valvassori SS, Luz G, Kapczinski F, Quevedo J. Brain creatine kinase activity in an animal model of mania. Life Sci. 2008;82(7-8):424-429.
21. Khuchua ZA, Qin W, Boero J, Cheng J, Payne RM, Saks VA, Strauss AW. Octamer formation and coupling of cardiac sarcomeric mitochondrial creatine kinase are mediated by charged N-terminal residues. J Biol Chem. 1998;273(36):22990-22996.
22. Schlattner U, Wallimann T. Octamers of mitochondrial creatine kinase isoenzymes differ in stability and membrane binding. J Biol Chem. 2000;275(23):17314-17320.
23. Saks VA, Kuznetsov AV, Kupriyanov VV, Miceli MV, Jacobus WE. Creatine kinase of rat heart mitochondria. The demonstration of functional coupling to oxidative phosphorylation in an inner membrane matrix preparation. J Biol Chem. 1985;260(12):7757-7764.
24. Soni SD. Serum creatine phosphokinase in acute psychosis. Br J Psychiatry. 1976;128(568):181-183.
25. Hermesh H, Stein D, Manor I, Shechtmann T, Blumensohn R, Meged S, Shiloh R, Benjamini Y, Weizmann A. Creatine kinase levels in untreated hospitalized adolescents during acute psychosis. J Am Acad Child Adolesc Psychiatry. 2002;41(9):1045-1053.
26. Kato T, Takahashi S, Shioiri T, Murashita J, Hamakawa H, Inubushi T. Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord. 1994;31(2):125-133.